Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase

Details for Australian Patent Application No. 2007260812 (hide)

Owner Amicus Therapeutics, Inc.

Inventors Wustman, Brandon

Agent Fisher Adams Kelly

Pub. Number AU-B-2007260812

PCT Pub. Number WO2007/150064

Priority 60/815,952 23.06.06 US

Filing date 25 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 16 August 2012

International Classifications

A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2007/150064 Priority application(s): WO2007/150064

16 August 2012 Application Accepted

  Published as AU-B-2007260812

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260817-DPYD gene variants and use thereof

2007260805-Carrier for containers